METHODS	A prospective , double blind , double-dummy , two-arm , parallel-group , 12-week study ( The STAR study ) was conducted to compare the efficacy and safety of solifenacin 5/10 mg and tolterodine extended release ( ER ) 4 mg in OAB patients .\